EQR
54
-5
UAL
70
7
CME
48
-4
MNST
59
2
ROK
44
-2
IPG
53
3
PWR
41
-2
CMG
57
-3
NSC
64
2
FSLR
46
2
GM
29
2
KMI
53
2
BXP
28
-13
JNPR
54
2
IVZ
45
2
AIZ
50
-2
EQT
60
3
IFF
59
-3
KLAC
61
-2
IR
40
-7
EQR
54
-5
UAL
70
7
CME
48
-4
MNST
59
2
ROK
44
-2
IPG
53
3
PWR
41
-2
CMG
57
-3
NSC
64
2
FSLR
46
2
GM
29
2
KMI
53
2
BXP
28
-13
JNPR
54
2
IVZ
45
2
AIZ
50
-2
EQT
60
3
IFF
59
-3
KLAC
61
-2
IR
40
-7
Financhill
Back

Celsius Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
14

CELH
Celsius Holdings

Last Price:
$22.34
Seasonality Move:
27.62%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
14
Celsius Holdings (CELH) is a Sell

Is Celsius Holdings a Buy, Sell or Hold?

  • The current Celsius Holdings [CELH] share price is $22.34. The Score for CELH is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • CELH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CELH Stock Price Chart

What is Celsius Holdings's stock price today?

  • The Celsius Holdings share price today is $22.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CELH is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CELH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.41 Sell
Relative Strength Index (14 RSI): 38.21 Sell
Chaikin Money Flow: -6720562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.59 - 26.67) Sell
Bollinger Bands (100): (25.37 - 31.59) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

CELH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.1 Buy
20-day SMA: 24 Sell
50-day SMA: 26.61 Sell
200-day SMA: 42.52 Sell
8-day EMA: 22.47 Sell
20-day EMA: 23.77 Sell
50-day EMA: 26.05 Sell
200-day EMA: 37.95 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Celsius Holdings Earnings Growth & CELH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.17 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Celsius Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):